(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||
* |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Exhibit No. | Description | |||||||
104 | Cover page interactive data file (formatted as Inline XBRL). |
PhaseBio Pharmaceuticals, Inc. | ||||||||||||||
Dated: December 2, 2022 | By: | /s/ Jonathan P. Mow | ||||||||||||
Jonathan P. Mow | ||||||||||||||
Chief Executive Officer |
Cover |
Nov. 21, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Nov. 28, 2022 |
Entity Registrant Name | PhaseBio Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38697 |
Entity Tax Identification Number | 03-0375697 |
Entity Address, Address Line One | 1 Great Valley Parkway |
Entity Address, Address Line Two | Suite 30 |
Entity Address, City or Town | Malvern |
Entity Address, State or Province | PA |
Entity Address, Postal Zip Code | 19355 |
City Area Code | 610 |
Local Phone Number | 981-6500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | PHASQ |
Security Exchange Name | NONE |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Amendment Flag | false |
Entity Central Index Key | 0001169245 |
P;28
MJ8VL9@/%W?W?:('*
M#(O)'R(]Z2,-BK3?ZG0PMJIE4-SIBPR.H9Y/H^ "78J65M4@*.[LGQ7X.-BZ
MDIBM-8CT>_2RV_%0HJH34-RMOVIA#)?P8)(DEP=3RVJI<*$%-"B.(5763W'?
MGJI8A,((N21/4-Y:L+B6!U=IY*FLG^).'6A^&<+CX3"_]LL?+B-8J+TL%B?R
MA^LUDE6N3W&3_H[L,
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end